Effectiveness of Two-dose Varicella Vaccination: Bayesian Network Meta-analysis
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: A 2-dose varicella vaccination strategy has been introduced in many countries worldwide, aiming to increase vaccine effectiveness (VE) against varicella infection. In this network meta-analysis, we aimed to provide a comprehensive evaluation and an overall estimated effect of varicella vaccination strategies, via a Bayesian model. Methods: For each eligible study, we collected trial characteristics, such as: 1-dose vs. 2-dose, demographic characteristics, and outcomes of interest. For studies involving different doses, we aggregated the data for the same number of doses delivered into one arm. The preventive effect of 1-dose vs. 2-dose of varicella vaccine were evaluated in terms of the odds ratio (OR) and corresponding equal-tailed 95% confidence interval (95% CI). Results: A total of 903 studies were retrieved during our literature search, and 25 interventional or observational studies were selected for the Bayesian network metaanalysis. A total of 49,265 observed individuals were included in this network meta-analysis. Compared to the 0-dose control group, the OR of all varicella infections were 0.087 (95% CI, 0.046–0.164) and 0.310 (95% CI, 0.198–0.484) for 2-doses and one-dose, respectively, which corresponded to VE of 69.0% (95% CI, 51.6–81.2) and VE of 91.3% (95% CI, 83.6–95.4) for 1- and 2-doses, respectively. Conclusions: A 2-dose vaccine strategy was able to significantly reduce varicella burden. The effectiveness of 2-dose vaccination on reducing the risk of infection was demonstrated by sound statistical evidence, which highlights the public health need for a 2-dose vaccine recommendation.
Abstract
Purpose: A 2-dose varicella vaccination strategy has been introduced in many countries worldwide, aiming to increase vaccine effectiveness (VE) against varicella infection. In this network meta-analysis, we aimed to provide a comprehensive evaluation and an overall estimated effect of varicella vaccination strategies, via a Bayesian model. Methods: For each eligible study, we collected trial characteristics, such as: 1-dose vs. 2-dose, demographic characteristics, and outcomes of interest. For studies involving different doses, we aggregated the data for the same number of doses delivered into one arm. The preventive effect of 1-dose vs. 2-dose of varicella vaccine were evaluated in terms of the odds ratio (OR) and corresponding equal-tailed 95% confidence interval (95% CI). Results: A total of 903 studies were retrieved during our literature search, and 25 interventional or observational studies were selected for the Bayesian network metaanalysis. A total of 49,265 observed individuals were included in this network meta-analysis. Compared to the 0-dose control group, the OR of all varicella infections were 0.087 (95% CI, 0.046–0.164) and 0.310 (95% CI, 0.198–0.484) for 2-doses and one-dose, respectively, which corresponded to VE of 69.0% (95% CI, 51.6–81.2) and VE of 91.3% (95% CI, 83.6–95.4) for 1- and 2-doses, respectively. Conclusions: A 2-dose vaccine strategy was able to significantly reduce varicella burden. The effectiveness of 2-dose vaccination on reducing the risk of infection was demonstrated by sound statistical evidence, which highlights the public health need for a 2-dose vaccine recommendation.
참고문헌 (39)
- Huang J, "The global disease burden of varicella-zoster virus infection from 1990 to 2019", J Med Virol, 94, pp.2736~2746 (2022)
- Nguyen HQ, "Decline in mortality due to varicella after implementation of varicella vaccination in the United States", N Engl J Med, 352, pp.450~458 (2005)
- Seward JF, "Varicella disease after introduction of varicella vaccine in the United States, 1995-2000", JAMA, 287, pp.606~611 (2002)
- Vázquez M, "Effectiveness over time of varicella vaccine", JAMA, 291, pp.851~855 (2004)
- Bonanni P, "Primary versus secondary failure after varicella vaccination : implications for interval between 2 doses", Pediatr Infect Dis J, 32, pp.e305~e313 (2013)
- Shapiro ED, "Effectiveness of 2 doses of varicella vaccine in children", J Infect Dis, 203, pp.312~315 (2011)
- Oh SH, "Varicella and varicella vaccination in South Korea", Clin Vaccine Immunol, 21, pp.762~768 (2014)
- Suh J, "The impact of two-dose varicella vaccination on varicella and herpes zoster incidence in South Korea using a mathematical model with changing population demographics", Vaccine, 39, pp.2575~2583 (2021)
- Lee YH, "The protective effectiveness of 2-dose varicella vaccination in children in Korea : a case-control study", Pediatr Infect Dis J, 42, pp.719~722 (2023)
- Higgins JP, "Consistency and inconsistency in network meta-analysis : concepts and models for multi-arm studies", Res Synth Methods, 3, pp.98~110 (2012)
- Hutton B, "The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions : checklist and explanations", Ann Intern Med, 162, pp.777~784 (2015)
- Kuter B, "Ten year follow-up of healthy children who received one or two injections of varicella vaccine", Pediatr Infect Dis J, 23, pp.132~137 (2004)
- Mahamud A, "Challenges in confirming a varicella outbreak in the two-dose vaccine era", Vaccine, 30, pp.6935~6939 (2012)
- Parker AA, "Challenges to implementing second-dose varicella vaccination during an outbreak in the absence of a routine 2-dose vaccination requirement--Maine, 2006", J Infect Dis, 197(Suppl 2), pp.S101~S107 (2008)
- Perella D, "Varicella vaccine effectiveness in preventing community transmission in the 2-dose era", Pediatrics, 137, pp.e20152802~ (2016)
- Thomas CA, "Two-dose varicella vaccine effectiveness and rash severity in outbreaks of varicella among public school students", Pediatr Infect Dis J, 33, pp.1164~1168 (2014)
- Hao B, "Efficacy, safety and immunogenicity of live attenuated varicella vaccine in healthy children in China : double-blind, randomized, placebo-controlled clinical trial", Clin Microbiol Infect, 25, pp.1026~1031 (2019)
- Nguyen MD, "Incremental effectiveness of second dose varicella vaccination for outbreak control at an elementary school in Philadelphia, Pennsylvania, 2006", Pediatr Infect Dis J, 29, pp.685~689 (2010)
- Lu L, "A varicella outbreak in a school with high one-dose vaccination coverage, Beijing, China", Vaccine, 30, pp.5094~5098 (2012)
- Wang Z, "Single-dose varicella vaccine effectiveness in school settings in China", Vaccine, 31, pp.3834~3838 (2013)
- Xu Y, "Epidemiology of varicella and effectiveness of varicella vaccine in Hangzhou, China, 2019", Hum Vaccin Immunother, 17, pp.211~216 (2021)
- Quinn HE, "Varicella vaccine effectiveness over 10 years in Australia; moderate protection from 1-dose program", J Infect, 78, pp.220~225 (2019)
- Vally H, "An outbreak of chickenpox at a child care centre in Western Australia. Costs to the community and implications for vaccination policy", Aust N Z J Public Health, 31, pp.113~119 (2007)
- Liese JG, "The effectiveness of varicella vaccination in children in Germany : a case-control study", Pediatr Infect Dis J, 32, pp.998~1004 (2013)
- Spackova M, "Comparative varicella vaccine effectiveness during outbreaks in day-care centres", Vaccine, 28, pp.686~691 (2010)
- Giaquinto C, "Impact of a vaccination programme in children vaccinated with ProQuad, and ProQuad-specific effectiveness against varicella in the Veneto region of Italy", BMC Infect Dis, 18, pp.103~ (2018)
- Tafuri S, "Report of varicella outbreak in a low vaccination coverage group of otherwise healthy children in Italy : the role of breakthrough and the need of a second dose of vaccine", Vaccine, 28, pp.1594~1597 (2010)
- Cenoz MG, "Effectiveness of one and two doses of varicella vaccine in preventing laboratory-confirmed cases in children in Navarre, Spain", Hum Vaccin Immunother, 9, pp.1172~1176 (2013)
- Latasa P, "Effectiveness and impact of a single-dose vaccine against chickenpox in the community of Madrid between 2001 and 2015", Hum Vaccin Immunother, 14, pp.2274~2280 (2018)
- Hattori F, "Evaluating the effectiveness of the universal immunization program against varicella in Japanese children", Vaccine, 35, pp.4936~4941 (2017)
- Andrade AL, "Single-dose varicella vaccine effectiveness in Brazil : a case-control study", Vaccine, 36, pp.479~483 (2018)
- Lee YH, "Effectiveness of varicella vaccination program in preventing laboratory-confirmed cases in children in Seoul, Korea", J Korean Med Sci, 31, pp.1897~1901 (2016)
- Kurugöl Z, "Outbreak of varicella in preschool children despite one-dose vaccination", Turk J Pediatr, 60, pp.56~62 (2018)
- Prymula R, "Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine versus one dose of monovalent varicella vaccine : a multicentre, observer-blind, randomised, controlled trial", Lancet, 383, pp.1313~1324 (2014)
- Gould PL, "An outbreak of varicella in elementary school children with two-dose varicella vaccine recipients--Arkansas, 2006", Pediatr Infect Dis J, 28, pp.678~681 (2009)
- Marin M, "Global varicella vaccine effectiveness : a meta-analysis", Pediatrics, 137, pp.e20153741~ (2016)
- Zhang Z, "Two-dose varicella vaccine effectiveness in China : a meta-analysis and evidence quality assessment", BMC Infect Dis, 21, pp.543~ (2021)
- Pawaskar M, "Relative efficacy of varicella vaccines : network meta-analysis of randomized controlled trials", Curr Med Res Opin, 38, pp.1772~1782 (2022)
- Hong K, "Waning effectiveness of one-dose universal varicella vaccination in Korea, 2011-2018 : a propensity score matched national population cohort", J Korean Med Sci, 36, pp.e222~ (2021)